2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Pancreatic Neoplasms
5
Cholangiocarcinoma
4
Colonic Neoplasms
3
Neoplasm Metastasis
2
Jaundice
2
Gallbladder Neoplasms
2
Fistula
2
Esophageal Neoplasms
2
Bites and Stings
2
Bile Duct Neoplasms
2
Anastomotic Leak
2
Urologic Diseases
1
Urolithiasis
1
Urinary Calculi
1
Ureterolithiasis
1
Ureteral Obstruction
1
Stomach Neoplasms
1
Stent Occlusion
1
Renal Insufficiency
1
Rectal Neoplasms
1
Pyonephrosis
1
Pyelonephritis
1
Obesity, Morbid
1
Obesity
1
Nephrolithiasis
1
Klatskin Tumor
1
Kidney Diseases
1
Kidney Calculi
1
Infections
1
Hydronephrosis
1
Interventions
Sorafenib
2
nimotuzumab
1
lenvatinib
1
atezolizumab
1
Tirapazamine
1
Stents
1
Radiotherapy
1
Radiosurgery
1
Radiofrequency Ablation
1
Immune Checkpoint Inhibitors
1
Hematologic Tests
1
Ethiodized Oil
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HCC
×
Stents
×
Clear all
NCT03108248
2017-04-11
ISP-TACE Versus TACE for HCC With PVTT
Zhongda Hospital
Completed
126 enrolled